Mealey's (March 12, 2020, 12:56 PM EDT) -- COLUMBUS, Ohio — E.I. du Pont de Nemours and Co. on March 10 filed a brief in Ohio federal court arguing that, despite the fact that its medical expert was excluded from testifying at trial in a cancer lawsuit related to exposure to perfluorooctanoic acid (known as C8), the expert should be permitted to testify in a joint trial for six cases that assert similar allegations and are included in same multidistrict litigation (In re: E.I. du Pont de Nemours and Co. C8 Personal Injury Litigation, MDL No. 2433, S.D. Ohio)....